Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Lilly Pharmaceutical’s Mounjaro (tirzepatide) is a once-weekly injection that promotes weight loss by mimicking the effects of incretins. This combination of a GLP-1 and a glucose-dependent insulinotropic polypeptide (GIP) yields weigh loss results comparable to surgical options.
Endocrinology, Diabetes, Metabolism May 17th 2022
Annals of Internal Medicine
Among adults aged 35 years or older with a body mass index (BMI) of 25 kg/m2, the prevalence of diabetes in Asian, Black, and Hispanic Americans was significantly higher than that in White Americans. Using screening thresholds specific to race and ethnicity has the potential to reduce disparities in diabetes diagnosis.
Medtelligence
The lipid metabolism plays an important role in the development of cardiovascular diseases and type 2 diabetes. However, little has been known about the molecular relationships. But now, a set of lipids have been statistically associated with cardiovascular disease and type 2 diabetes.
Cardiology May 3rd 2022
Primary hyperparathyroidism (PHPT) is associated with increased risk for fractures, cardiovascular disease, kidney disease, and cancer, along with increased mortality. In mild PHPT with modest hypercalcemia and without known morbidities, parathyroidectomy is debated because no long-term randomized trials have been performed related to it.
Cardiology April 27th 2022
Drinking beer and spirits is linked to elevated levels of visceral fat, which is associated with increased risk of cardiovascular disease, metabolic syndrome, and other health complications. Moderate wine consumption shows no such association with levels of this harmful fat and may even protect against it.
Cleveland Clinic Journal of Medicine
Hyperglycemia is associated with poor clinical outcomes in critically ill patients. Most medical societies recommend less stringent glucose control, in the range of 140 to 180 mg/dL, for critically ill patients. In this population, although glucose management is essential, hypoglycemia is associated with increased mortality. Enhancing the amount of time glucose levels are in the target range and minimizing glycemic variability have been associated with improved outcomes in critically ill patients.
Endocrinology, Diabetes, Metabolism April 27th 2022